About Us
Flagship Biosciences is a CLIA-Certified and CAP-Accredited technology-driven spatial biology and biomarker services company, revolutionizing drug development and diagnostics through AI-powered analysis and expert consultation. Since 2009, we’ve delivered the most accurate, insightful data—eliminating variability of traditional methods and uncovering new biological insights. Our scientists don’t just deliver results—they interpret them, offering clear guidance to drive your success.
About Us
Flagship Biosciences is a technology-driven spatial biology and biomarker services company, revolutionizing drug development and diagnostics through AI-powered analysis and expert consultation. Since 2009, we’ve delivered the most accurate, insightful data—eliminating variability of traditional methods and uncovering new biological insights. Our scientists don’t just deliver results—they interpret them, offering clear guidance to drive your success.
We are passionate about improving patient outcomes.
We support our partners with responsive, expert-driven service—combining AI-powered biomarker analysis with personalized scientific consultation to deliver clear, actionable insights every step of the way.
We are passionate about improving patient outcomes.
We support our partners with responsive, expert-driven service—combining AI-powered biomarker analysis with personalized scientific consultation to deliver clear, actionable insights every step of the way.
Our Mission
At Flagship Biosciences, our mission is to improve patient outcomes by empowering pharmaceutical and biotech companies with advanced spatial biology and biomarker insights. Through our AI-driven technology and expert scientific consultation, we help our partners make more informed decisions in drug development and diagnostics—accelerating the path from discovery to impactful therapies.
Our Partners
Our Mission
At Flagship Biosciences, our mission is to improve patient outcomes by empowering pharmaceutical and biotech companies with advanced spatial biology and biomarker insights. Through our AI-driven technology and expert scientific consultation, we help our partners make more informed decisions in drug development and diagnostics—accelerating the path from discovery to impactful therapies.
Our Partners
Leadership
Thomas Turi, Ph.D.
Chief Executive Officer
Roberto Gianani, M.D.
Chief Medical Officer